QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
NASDAQ:NBRV

Nabriva Therapeutics Insider Trades

$0.44
-0.05 (-10.15%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.43
$0.50
50-Day Range
$0.45
$0.99
52-Week Range
$0.41
$3.49
Volume
432,415 shs
Average Volume
600,552 shs
Market Capitalization
$240.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.64

Nabriva Therapeutics (NASDAQ:NBRV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.86%

Number Of
Insiders Buying
(Last 12 Months)
3

Amount Of
Insider Buying
(Last 12 Months)
$117.63 K

Number Of
Insiders Selling
(Last 12 Months)
1

Amount Of
Insider Selling
(Last 12 Months)
$932.40

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get NBRV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nabriva Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Nabriva Therapeutics (NASDAQ NBRV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2021Theodore R SchroederCEOBuy100,000$0.57$57,000.00  
12/27/2021J. Christopher NaftzgerGeneral CounselBuy7,000$0.59$4,130.00  
9/14/2021Theodore R. SchroederCEOBuy50,000$1.13$56,500.00226,875  
8/2/2021Stephen W. WebsterDirectorSell777$1.20$932.4018,473  
8/20/2020Colin Md BroomDirectorSell11,064$0.65$7,191.60260,000  
8/30/2019Colin Md BroomDirectorBuy10,177$2.03$20,659.31  
8/27/2019Theodore R SchroederCEOBuy50,000$1.79$89,500.005,786  
8/22/2019Francesco Maria LavinoInsiderBuy4,800$2.04$9,792.0015,972  
8/21/2019Colin Md BroomDirectorSell10,177$2.07$21,066.39125,724  
8/21/2019Gary SenderCFOSell3,390$2.08$7,051.2019,214  
8/21/2019Steven P GeloneCOOSell8,206$2.08$17,068.4852,386  
12/24/2018Charles A Rowland JrDirectorBuy53,000$1.31$69,430.0053,000  
7/31/2018Daniel D BurgessDirectorBuy36,000$2.75$99,000.0036,000  
6/22/2018Colin Md BroomCEOBuy5,000$3.72$18,600.00102,151  
6/22/2018Jennifer SchranzInsiderBuy5,500$3.73$20,515.005,500  
5/23/2018Francesco Maria LavinoInsiderBuy2,160$4.60$9,936.003,719  
5/23/2018Gary SenderCFOBuy2,000$4.57$9,140.006,200  
5/23/2018Robert CrottyGeneral CounselBuy10,000$4.48$44,800.0010,000  
5/23/2018Stephen W WebsterDirectorBuy8,000$4.59$36,720.008,000  
11/29/2017Francesco Maria LavinoInsiderBuy1,569$6.29$9,869.01  
9/22/2017Colin Md BroomCEOBuy2,588$8.35$21,609.8087,151  
9/22/2017Gary SenderCFOBuy2,000$8.21$16,420.004,200  
9/18/2017Vivo Capital Viii, LlcMajor ShareholderBuy52,631$9.46$497,889.26  
9/14/2017Hbm Healthcare Investments (CaMajor ShareholderSell36,608$8.56$313,364.48  
8/31/2017Hbm Healthcare Investments (CaMajor ShareholderSell639$9.50$6,070.502,370,735  
8/8/2017Hbm Healthcare Investments (CaMajor ShareholderSell19,803$10.50$207,931.502,373,387  
8/7/2017Hbm Healthcare Investments (CaMajor ShareholderSell17,790$10.50$186,795.002,373,387  
7/28/2017Hbm Healthcare Investments (CaMajor ShareholderSell6,585$10.51$69,208.352,391,177  
7/24/2017Hbm Healthcare Investments (CaMajor ShareholderSell160$10.50$1,680.002,397,762  
7/20/2017Hbm Healthcare Investments (CaMajor ShareholderSell44,231$10.50$464,425.502,421,367  
7/18/2017Hbm Healthcare Investments (CaMajor ShareholderSell69,854$10.51$734,165.542,490,952  
7/13/2017Hbm Healthcare Investments (CaMajor ShareholderSell57,175$10.53$602,052.752,565,661  
7/7/2017Hbm Healthcare Investments (CaMajor ShareholderSell2,695$10.52$28,351.402,569,315  
7/3/2017Hbm Healthcare Investments (CaMajor ShareholderSell13,127$10.94$143,609.382,583,229  
6/30/2017Hbm Healthcare Investments (CaMajor ShareholderSell1,775$10.94$19,418.502,583,229  
6/29/2017Hbm Healthcare Investments (CaMajor ShareholderSell8,558$10.96$93,795.682,591,396  
6/19/2017George Harrison TalbotDirectorSell170$93.18$15,840.603,249  
5/30/2017George Harrison TalbotDirectorSell210$101.26$21,264.603,449  
5/25/2017George Harrison TalbotDirectorSell325$100.56$32,682.003,854  
5/16/2017George Harrison TalbotDirectorSell200$102.44$20,488.003,351  
5/15/2017George Harrison TalbotDirectorSell50$101.50$5,075.003,351  
4/28/2017Hbm Healthcare Investments (CaMajor ShareholderSell15,939$11.02$175,647.782,609,192  
4/21/2017Hbm Healthcare Investments (CaMajor ShareholderSell2,622$11.04$28,946.882,609,901  
4/20/2017Hbm Healthcare Investments (CaMajor ShareholderSell23,932$11.11$265,884.522,624,633  
4/13/2017Hbm Healthcare Investments (CaMajor ShareholderSell32,831$11.24$369,020.442,660,689  
4/10/2017Hbm Healthcare Investments (CaMajor ShareholderSell90,594$10.96$992,910.24269,371  
(Data available from 1/1/2013 forward)












Nabriva Therapeutics (NASDAQ:NBRV) Insider Trade Frequently Asked Questions

Who is on Nabriva Therapeutics's Insider Roster?

The list of insiders at Nabriva Therapeutics includes Colin Md Broom, Francesco Maria Lavino, Gary Sender, J. Christopher Naftzger, Stephen W. Webster, Steven P Gelone, Theodore R Schroeder.Learn more on NBRV's insiders

What percentage of Nabriva Therapeutics stock is owned by insiders?

0.86% of Nabriva Therapeutics stock is owned by insiders. Learn more on NBRV's insider holdings

Which Nabriva Therapeutics insiders have been buying company stock?

The following insiders have purchased Nabriva Therapeutics stock in the last 24 months: J. Christopher Naftzger ($4,130.00), and Theodore R Schroeder ($57,000.00).

How much insider buying is happening at Nabriva Therapeutics?

Insiders have purchased a total of 157,000 Nabriva Therapeutics shares in the last 24 months for a total of $117,630.00 bought.

Which Nabriva Therapeutics insiders have been selling company stock?

The following insiders have sold Nabriva Therapeutics stock in the last 24 months: Colin Md Broom ($7,191.60), and Stephen W. Webster ($932.40).

How much insider selling is happening at Nabriva Therapeutics?

Insiders have sold a total of 11,841 Nabriva Therapeutics shares in the last 24 months for a total of $8,124.00 sold.

This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.